Oral

[O3-4] Orthomyxo/Paramyxovirus

Tue. Nov 15, 2022 2:30 PM - 3:45 PM Room 4 (Conference Room 107)

Chair:Takeshi Ichinohe(Institute of Medical Science, The University of Tokyo), Keisuke Ohta(Wakayama Medical Unversity)

+Add all to schedule

2:30 PM - 2:45 PM

[O3-4-7] Characterizations of circulating influenza viruses in the 2021/22 season and selection of vaccine viruses for the 2022/23 season

*Shinji Watanabe¹, Noriko Kishida¹, Seiichiro Fujisaki¹, Kazuya Nakamura¹, Masayuki Shirakura¹, Emi Takashita¹, Aya Sato¹, Miki Akimoto¹, Hideka Miura¹, Hiroko Morita¹, Shiho Nagata¹, Hiromi Sugawara¹, Hideki Hasegawa¹, The influenza surveillance group of Japan² (1. National Institute of Infectious Diseases, 2. Public Health Institutes and Public Health Centers of Local Government and Clinics in Japan)

2:45 PM - 3:00 PM

[O3-4-8] Assessment of Fcγ receptor-dependent immune response of influenza vaccine induced antibodies in the non-human primate model

*Yuji Masuta¹, Shokichi Takahama¹, Takuto Nogimori¹, Saya Moriyama², Yoshimasa Takahashi², Takuya Yamamoto^1,3,4 (1. Laboratory of Immunosenescence, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, 2. Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, 3. Laboratory of Aging and Immune Regulation, Graduate School of Pharmaceutical Sciences, Osaka University, 4. Department of Virology and Immunology, Graduate School of Medicine, Osaka University)

3:00 PM - 3:15 PM

[O3-4-9] High body temperature increases gut microbiota-dependent host resistance to influenza A virus and SARS-CoV-2 infection

Minami Nagai¹, Miyu Moriyama², Yuuka Nitta¹, Noriko Arimitsu¹, Moe Nishimoto¹, *Takeshi Ichinohe¹ (1. Institute of Medical Science, The University of Tokyo, 2. Yale University)

3:15 PM - 3:30 PM

[O3-4-10] Identification of an aseptic meningitis causative variant clone in a current Japanese mumps vaccine and refinement of the vaccine.

*Minoru Kidokoro¹, Keiko Murano¹, Yasushi Ami¹, Fumihiro Katou¹, Hiroshi Katoh¹, Suga Shigeru² (1. National Institute of Infectious Diseases, 2. National Hospital Organization Mie National Hospital)

3:30 PM - 3:45 PM

[O3-4-11] Bilocus injections of the vaccinia vectors encoding nipah virus glycoproteins enhance to induce neutralization antibody.

*Shumpei Watanabe^1,2, Tomoki Yoshikawa², Yoshihiro Kaku³, Takeshi Kurosu², Fukushi Shuetsu², Satoko Sugimoto², Yuki Nishisaka¹, Hikaru Fujii¹, Hideki Ebihara², Shigeru Morikawa¹, Masayuki Shimojima², Masayuki Saijo^2,4 (1. Okayama University of Science, 2. Department of Virology I, National Institute of Infectious Diseases, 3. Division of Veterinary Science, National Institute of Infectious Diseases, 4. Public Health Office, Sapporo Health & Welfare Bureau )

Session information